Table 1 Mean characteristics of patients admitted from January to December 2017
Boys (n = 112) | Girls (n = 91) | P value | |
|---|---|---|---|
Age, months | 2.4 (1–10) | 3.3 (1–12) | ns |
Hospitalization (days) | 5.13 (6–19) | 5.8 (1–19) | ns |
Illness duration (days) | 10.5 (6–20) | 8.7 (3–19) | ns |
CRP, mg/dL | 0.92 (range 0.46–6.28) | 1.11 (range 0.36–14.32) | P < 0.05 |
RSVB (% of patients) | 58% | 47% | P = 0.030 |
RSVA (% of patients) | 11.6% | 16% | ns |
Rhinovirus (% of patients) | 6.25% | 4% | ns |
Metavirus | 9.8% | 7% | ns |
Other viruses | 7.1% | 19% | P = 0.05 |
Coinfections (% of patients) | 4.46% | 7% | ns |
Complications of the disease | 12.5% | 11% | ns |
Mild thrombocytosis | 78.3% | 90% | P = 0.01 |
Severe thrombocytosis | 21.7% | 10% | P = 0.05 |
Oxygen therapy (% of patients) | 42.86.% | 48% | ns |
Cortisone therapy (% of patients) | 46.4% | 60% | P = 0.05 |
Antibiotic therapy (% of patients) | 35.7% | 35% | ns |
Aerosol therapy with 2 ml of 3% hypertonic solution (% of patients) | 62% | 54% | ns |